Campbell, Marion K

Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)

Beard, D. J., Campbell, M. K., Blazeby, J. M., Carr, A. J., Weijer, C., Cuthbertson, B. H., Buchbinder, R., Pinkney, T., Bishop, F. L., Pugh, J., et al. (2020) · The Lancet

Statistical Methods in Clinical TrialsPain Management and Placebo Effect

Cited by 96

What, how, when and who of trial results summaries for trial participants: stakeholder-informed guidance from the RECAP project

Bruhn, H., Campbell, M., Entwistle, V., Humphreys, R., Jayacodi, S., Knapp, P., Tizzard, J., & Gillies, K. (2022) · BMJ Open

Ethics in Clinical ResearchHealth Policy Implementation Science

Cited by 47

Subversion of allocation concealment in a randomised controlled trial: a historical case study.

Kennedy, A. D. M., Torgerson, D. J., Campbell, M. K., & Grant, A. M. (2017) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 44

Exploring the role and function of trial steering committees: results of an expert panel meeting

Harman, N. L., Conroy, E. J., Lewis, S. C., Murray, G., Norrie, J., Sydes, M. R., Lane, J. A., Altman, D. G., Baigent, C., Bliss, J. M., et al. (2015) · Trials

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 33

Developing the specifications of an open angle glaucoma screening intervention in the United Kingdom: a Delphi approach

Campbell, S. E., Azuara-Blanco, A., Campbell, M. K., Francis, J. J., Greene, A. C., Ramsay, C. R., & Burr, J. M. (2012) · BMC Health Services Research

Glaucoma and retinal disordersOphthalmology and Visual Impairment Studies

Cited by 13